Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -6,570 | -4,970 | -3,680 | -7,870 |
| Depreciation Amortization | N/A | 460 | 540 | 760 | 710 |
| Other Working Capital | N/A | 1,750 | 340 | -230 | 960 |
| Other Operating Activity | 0 | 3,450 | 1,510 | 790 | 2,810 |
| Operating Cash Flow | $N/A | $-910 | $-2,580 | $-2,360 | $-3,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -10 | -40 | -30 |
| Net Acquisitions | N/A | 0 | 0 | 0 | -1 |
| Other Investing Activity | 0 | 42 | 0 | 0 | 191 |
| Investing Cash Flow | $N/A | $40 | $-10 | $-40 | $160 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 910 | 2,680 | 2,320 | 3,210 |
| Financing Cash Flow | $N/A | $910 | $2,680 | $2,320 | $3,210 |
| Exchange Rate Effect | N/A | -80 | -50 | 70 | -10 |
| Beginning Cash Position | N/A | 40 | 9 | 10 | 40 |
| End Cash Position | N/A | 4 | 40 | 9 | 10 |
| Net Cash Flow | $N/A | $-30 | $30 | $-9 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -910 | -2,580 | -2,360 | -3,390 |
| Free Cash Flow | 0 | -910 | -2,580 | -2,360 | -3,390 |